A detailed history of Wallace Advisory Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 7,388 shares of JNJ stock, worth $1.14 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
7,388
Previous 7,585 2.6%
Holding current value
$1.14 Million
Previous $1.18 Billion 1.98%
% of portfolio
0.87%
Previous 0.93%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$155.22 - $162.74 $30,578 - $32,059
-197 Reduced 2.6%
7,388 $1.16 Billion
Q4 2023

Jan 08, 2024

SELL
$145.6 - $158.88 $40,476 - $44,168
-278 Reduced 3.54%
7,585 $1.18 Billion
Q3 2023

Oct 05, 2023

SELL
$155.75 - $174.48 $8,877 - $9,945
-57 Reduced 0.72%
7,863 $1.3 Billion
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $3,927 - $4,686
-26 Reduced 0.33%
7,920 $1.23 Billion
Q4 2022

Feb 21, 2023

BUY
$160.2 - $179.79 $1.27 Million - $1.43 Million
7,946 New
7,946 $1.4 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Wallace Advisory Group, LLC Portfolio

Follow Wallace Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallace Advisory Group, LLC with notifications on news.